These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1756714)

  • 1. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins.
    Hancock JF; Cadwallader K; Paterson H; Marshall CJ
    EMBO J; 1991 Dec; 10(13):4033-9. PubMed ID: 1756714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane.
    Hancock JF; Paterson H; Marshall CJ
    Cell; 1990 Oct; 63(1):133-9. PubMed ID: 2208277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular localization of the P21rho proteins.
    Adamson P; Paterson HF; Hall A
    J Cell Biol; 1992 Nov; 119(3):617-27. PubMed ID: 1383236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization.
    Cadwallader KA; Paterson H; Macdonald SG; Hancock JF
    Mol Cell Biol; 1994 Jul; 14(7):4722-30. PubMed ID: 8007974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway.
    Apolloni A; Prior IA; Lindsay M; Parton RG; Hancock JF
    Mol Cell Biol; 2000 Apr; 20(7):2475-87. PubMed ID: 10713171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and proteolysis are essential for efficient membrane binding of prenylated p21K-ras(B).
    Hancock JF; Cadwallader K; Marshall CJ
    EMBO J; 1991 Mar; 10(3):641-6. PubMed ID: 2001678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-translational modifications of p21rho proteins.
    Adamson P; Marshall CJ; Hall A; Tilbrook PA
    J Biol Chem; 1992 Oct; 267(28):20033-8. PubMed ID: 1400319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the phosphatidylinositol 3-kinase/mTOR pathway.
    Takahashi K; Nakagawa M; Young SG; Yamanaka S
    J Biol Chem; 2005 Sep; 280(38):32768-74. PubMed ID: 16046393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein.
    Cox AD; Hisaka MM; Buss JE; Der CJ
    Mol Cell Biol; 1992 Jun; 12(6):2606-15. PubMed ID: 1375323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras (CXXX) and Rab (CC/CXC) prenylation signal sequences are unique and functionally distinct.
    Khosravi-Far R; Clark GJ; Abe K; Cox AD; McLain T; Lutz RJ; Sinensky M; Der CJ
    J Biol Chem; 1992 Dec; 267(34):24363-8. PubMed ID: 1332953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient palmitoylation supports H-Ras membrane binding but only partial biological activity.
    Coats SG; Booden MA; Buss JE
    Biochemistry; 1999 Sep; 38(39):12926-34. PubMed ID: 10504264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivatives of activated H-ras lacking C-terminal lipid modifications retain transforming ability if targeted to the correct subcellular location.
    Hart KC; Donoghue DJ
    Oncogene; 1997 Feb; 14(8):945-53. PubMed ID: 9050994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation.
    Cox AD; Garcia AM; Westwick JK; Kowalczyk JJ; Lewis MD; Brenner DA; Der CJ
    J Biol Chem; 1994 Jul; 269(30):19203-6. PubMed ID: 8034681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase.
    Schaber MD; O'Hara MB; Garsky VM; Mosser SC; Bergstrom JD; Moores SL; Marshall MS; Friedman PA; Dixon RA; Gibbs JB
    J Biol Chem; 1990 Sep; 265(25):14701-4. PubMed ID: 2203759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prenyl-polybasic domain code determines lipid-binding specificity of the K-Ras membrane anchor.
    Zhou Y; Hancock JF
    Small GTPases; 2020 May; 11(3):220-224. PubMed ID: 29239694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice.
    Sebti SM; Tkalcevic GT; Jani JP
    Cancer Commun; 1991 May; 3(5):141-7. PubMed ID: 2043425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function.
    Huang DC; Marshall CJ; Hancock JF
    Mol Cell Biol; 1993 Apr; 13(4):2420-31. PubMed ID: 8455619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21ras is modified by a farnesyl isoprenoid.
    Casey PJ; Solski PA; Der CJ; Buss JE
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8323-7. PubMed ID: 2682646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maize ROP7 GTPase contains a unique, CaaX box-independent plasma membrane targeting signal.
    Ivanchenko M; Vejlupkova Z; Quatrano RS; Fowler JE
    Plant J; 2000 Oct; 24(1):79-90. PubMed ID: 11029706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effector domain of Rab6, plus a highly hydrophobic C terminus, is required for Golgi apparatus localization.
    Beranger F; Paterson H; Powers S; de Gunzburg J; Hancock JF
    Mol Cell Biol; 1994 Jan; 14(1):744-58. PubMed ID: 8264642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.